Institutional members access full text with Ovid®

Share this article on:

Comparison of Fecal Inflammatory Markers in Crohn's Disease

Wright, Emily K. MD; Kamm, Michael A. MD, PhD; De Cruz, Peter MD, PhD; Hamilton, Amy L. BSc; Ritchie, Kathryn J. BN; Keenan, Jacqueline I. PhD; Leach, Steven PhD; Burgess, Laura MSc; Aitchison, Alan BSc; Gorelik, Alexandra MSc; Liew, Danny MD, PhD; Day, Andrew S. MD, PhD; Gearry, Richard B. MD, PhD

doi: 10.1097/MIB.0000000000000671
Original Article

Background: Fecal biomarkers are used increasingly to monitor Crohn's disease (CD). However, the relative accuracy of different markers in identifying inflammation has been poorly evaluated. We evaluated fecal calprotectin (FC), lactoferrin (FL), and S100A12 (FS) using endoscopic validation in a prospective study of the progression of CD after intestinal resection.

Methods: Data were collected from 135 participants in a prospective, randomized, controlled trial aimed at preventing postoperative CD recurrence. Three hundred nineteen stool samples were tested for FC, FL, and FS preoperatively and 6, 12, and 18 months after resection. Colonoscopy was performed at 6 and/or 18 months. Endoscopic recurrence was assessed blindly using the Rutgeerts score. C-reactive protein (CRP) and Crohn's Disease Activity Index (CDAI) were assessed.

Results: FC, FL, and FS concentrations were elevated preoperatively (median: 1347, 40.9, and 8.4 μg/g, respectively). At 6 months postoperatively, marker concentrations decreased (166, 3.0, 0.9 μg/g) and were higher in recurrent disease than remission (275 versus 72 μg/g, P < 0.001; 5.7 versus 1.6 μg/g, P = 0.007; 2.0 versus 0.8 μg/g, P = 0.188). FC > 135 μg/g, FL > 3.4 μg/g, and FS > 10.5 μg/g indicated endoscopic recurrence (score ≥ i2) with a sensitivity, specificity, and negative predictive value (NPV) of 0.87, 0.66, and 91%; 0.70, 0.68, and 81%; 0.91, 0.12, and 71%, respectively. FC and FL correlated significantly with the presence and severity of endoscopic recurrence, whereas FS, CRP and CDAI did not.

Conclusions: FC was the optimal fecal marker for monitoring disease activity in postoperative CD and was superior to CRP and CDAI. FL offered modest sensitivity for detecting recurrent disease, whereas S100A12 was sensitive but had low specificity and NPV.

Article first published online 28 January 2016.

*Department of Gastroenterology, St Vincent's Hospital and University of Melbourne, Melbourne, Australia;

Imperial College London, London, United Kingdom;

Department of Surgery, University of Otago, Christchurch, New Zealand;

§School of Women's and Children's Health, University of NSW, Sydney, Australia;

Department of Paediatrics, University of Otago, Christchurch, New Zealand;

Melbourne EpiCentre, University of Melbourne and Melbourne Health, Melbourne, Australia; and

**Department of Medicine, University of Otago, Christchurch, New Zealand.

Reprints: Michael A. Kamm, MD, PhD, St Vincent's Hospital, Victoria Parade, Fitzroy 3065, Melbourne, Australia (e-mail: mkamm@unimelb.edu.au).

The authors have no conflict of interest to disclose.

Received September 16, 2015

Accepted October 16, 2015

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website